1. Home
  2. SWTX vs TDC Comparison

SWTX vs TDC Comparison

Compare SWTX & TDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • TDC
  • Stock Information
  • Founded
  • SWTX 2017
  • TDC 1979
  • Country
  • SWTX United States
  • TDC United States
  • Employees
  • SWTX N/A
  • TDC N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • TDC Computer Software: Prepackaged Software
  • Sector
  • SWTX Health Care
  • TDC Technology
  • Exchange
  • SWTX Nasdaq
  • TDC Nasdaq
  • Market Cap
  • SWTX 3.0B
  • TDC 3.1B
  • IPO Year
  • SWTX 2019
  • TDC 2007
  • Fundamental
  • Price
  • SWTX $58.25
  • TDC $23.31
  • Analyst Decision
  • SWTX Strong Buy
  • TDC Hold
  • Analyst Count
  • SWTX 6
  • TDC 11
  • Target Price
  • SWTX $70.83
  • TDC $32.90
  • AVG Volume (30 Days)
  • SWTX 3.2M
  • TDC 1.2M
  • Earning Date
  • SWTX 02-20-2025
  • TDC 02-11-2025
  • Dividend Yield
  • SWTX N/A
  • TDC N/A
  • EPS Growth
  • SWTX N/A
  • TDC 90.16
  • EPS
  • SWTX N/A
  • TDC 1.16
  • Revenue
  • SWTX $191,589,000.00
  • TDC $1,750,000,000.00
  • Revenue This Year
  • SWTX $3,475.18
  • TDC N/A
  • Revenue Next Year
  • SWTX $81.60
  • TDC $1.01
  • P/E Ratio
  • SWTX N/A
  • TDC $20.10
  • Revenue Growth
  • SWTX 3417.33
  • TDC N/A
  • 52 Week Low
  • SWTX $28.21
  • TDC $22.73
  • 52 Week High
  • SWTX $62.00
  • TDC $39.70
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 70.71
  • TDC 16.80
  • Support Level
  • SWTX $54.89
  • TDC $22.73
  • Resistance Level
  • SWTX $62.00
  • TDC $31.34
  • Average True Range (ATR)
  • SWTX 4.09
  • TDC 0.80
  • MACD
  • SWTX 1.35
  • TDC -0.75
  • Stochastic Oscillator
  • SWTX 85.90
  • TDC 6.18

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

About TDC Teradata Corporation

Teradata Corp provides analytic data products and related services. The Company operates in data and analytics, which captures, integrates, stores, manages, and analyzes data of all types to answer business questions and deliver insight; and marketing applications, which offer marketing management products to help businesses win customer loyalty. Its solutions include components such as data warehousing, Asset optimization, Fraud prevention, Product innovation, and risk mitigation. A majority of the firm's revenue is generated in the United States.

Share on Social Networks: